LIVE
4.1M influencer listings 🏢50.5K sponsor listings 🌍67.3B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋1.6M Bluesky creators 🎙️1.1M podcast creators 🟣789.5K Twitch creators 🐘156.8K Mastodon creators 🥊99.1K Kick creators ▶️81.7K YouTube creators 𝕏73.1K X creators 📈58.1K Pinterest creators ✈️55.7K Telegram creators 🎵32.8K TikTok creators 🎮8K Discord creators 🎬4K Rumble creators 📈2.2K Substack creators 🧵1.5K Threads creators 4.1M influencer listings 🏢50.5K sponsor listings 🌍67.3B combined audience reach 📊13 platforms indexed 🗺️130+ countries covered 🏷️10,000+ niches 🦋1.6M Bluesky creators 🎙️1.1M podcast creators 🟣789.5K Twitch creators 🐘156.8K Mastodon creators 🥊99.1K Kick creators ▶️81.7K YouTube creators 𝕏73.1K X creators 📈58.1K Pinterest creators ✈️55.7K Telegram creators 🎵32.8K TikTok creators 🎮8K Discord creators 🎬4K Rumble creators 📈2.2K Substack creators 🧵1.5K Threads creators
melanomda neoadjuvan tedavi

melanomda neoadjuvan tedavi

Podcast health
🔄 Data last refreshed 1 day ago
🤝

Make a deal with melanomda neoadjuvan tedavi

🔒 Paid proposals held safely in escrow — released only when the work's approved.

Every booking is a normal escrow-protected deal.

Ratings
N/A
Episodes
1
Latest episode
1 year ago
🎁 Free analysisfor melanomda neoadjuvan tedavi

👥 Audience demographics

Estimated

Modeled from this creator's niche, platform & region — a planning estimate, not connected analytics.

Gender split
Male 54% Female 46%
Age · peak 18-24
13-1711%
18-2433%
25-3432%
35-4416%
45+8%
Top geographies
  • United States34%
  • India11%
  • United Kingdom8%
  • Brazil6%
  • Indonesia5%
Likely interests
EntertainmentLifestyleTrending

💚 Brand affinity

Estimated

Brands melanomda neoadjuvan tedavi's audience is most likely to respond to — from detected sponsorships in this niche.

Keeps Gymshark Epidemic Sound Bachelor Recipes BetterHelp Nooance Paris Stylevana Manscaped Audible Park Road Studios

About

Neoadjuvant Therapy, John R. Hyngstrom MDSurgical Oncology Clinics of North America, 2025-07-01, Volume 34, Issue 3, Pages 375-392 derlemsinin notebooklm tarafından hazırlanan podcasti: Makale, makroskobik Evre III ve rezeke edilebilir Evre IV melanom tedavisindeki değişiklikleri tartışmaktadır. Özellikle ameliyat öncesi (neoadjuvan) immünoterapi kullanımının standart ameliyat ve ameliyat sonrası (adjuvan) tedaviye kıyasla üstünlüğünü vurgulamaktadır. Makalede çeşitli klinik denemeler incelenmekte, immünoterapi ve hedefe yönelik tedavilerin patolojik yanıt oranları, advers olaylar ve hastalık nüksü olmadan sağkalım üzerindeki etkileri değerlendirilmektedir. Ayrıca, patolojik yanıtın ilerideki tedavileri yönlendirebilecek önemli bir prognostik bilgi sağladığı belirtilmektedir. Genel olarak makale, yüksek riskli rezeke edilebilir melanom hastaları için neoadjuvan immünoterapinin yeni bir standart olarak kabul edildiğini öne sürmektedir.

✉ Message melanomda neoadjuvan tedavi

Reaching out to influencers is a Pro feature. Upgrade to message any influencer directly — perfect for brands and agencies booking sponsorships.

See Pro $9.95/mo →

Already Pro? Log in.

🎤 Event / appearance with melanomda neoadjuvan tedavi

Booking an event / appearance is a Pro feature. Upgrade to book melanomda neoadjuvan tedavi for an in-person or virtual appearance — payment held safely in escrow until the event is done.

See Pro $9.95/mo →

Already Pro? Log in.

Auto-generated from Podcast's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove